Annual Net Income:
$1.20B+$210.30M(+21.35%)Summary
- As of April 4, 2025, UTHR annual net profit is $1.20 billion, with the most recent change of +$210.30 million (+21.35%) on December 31, 2024.
- During the last 3 years, UTHR annual net income has risen by +$719.30 million (+151.18%).
- UTHR annual net income is now at all-time high.
Performance
UTHR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income:
$301.30M-$7.80M(-2.52%)Summary
- As of April 4, 2025, UTHR quarterly net profit is $301.30 million, with the most recent change of -$7.80 million (-2.52%) on December 31, 2024.
- Over the past year, UTHR quarterly net income has stayed the same.
- UTHR quarterly net income is now -35.12% below its all-time high of $464.40 million, reached on September 30, 2015.
Performance
UTHR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income:
$1.20B+$84.20M(+7.58%)Summary
- As of April 4, 2025, UTHR TTM net profit is $1.20 billion, with the most recent change of +$84.20 million (+7.58%) on December 31, 2024.
- Over the past year, UTHR TTM net income has stayed the same.
- UTHR TTM net income is now at all-time high.
Performance
UTHR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
UTHR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.4% | 0.0% | 0.0% |
| 3 y3 years | +151.2% | 0.0% | 0.0% |
| 5 y5 years | +1243.6% | 0.0% | 0.0% |
UTHR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.2% | -2.5% | +159.7% | at high | +89.5% |
| 5 y | 5-year | at high | +1243.6% | -2.5% | +964.7% | at high | +194.8% |
| alltime | all time | at high | +1243.6% | -35.1% | +160.9% | at high | +897.3% |
United Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.20B(+21.4%) | $301.30M(-2.5%) | $1.20B(+7.6%) |
| Sep 2024 | - | $309.10M(+11.1%) | $1.11B(+3.9%) |
| Jun 2024 | - | $278.10M(-9.3%) | $1.07B(+1.8%) |
| Mar 2024 | - | $306.60M(+41.2%) | $1.05B(+6.7%) |
| Dec 2023 | $984.80M(+35.4%) | $217.10M(-18.9%) | $984.80M(+9.4%) |
| Sep 2023 | - | $267.60M(+3.2%) | $899.80M(+3.2%) |
| Jun 2023 | - | $259.20M(+7.6%) | $871.50M(+19.7%) |
| Mar 2023 | - | $240.90M(+82.4%) | $728.30M(+0.1%) |
| Dec 2022 | $727.30M(+52.9%) | $132.10M(-44.8%) | $727.30M(+2.8%) |
| Sep 2022 | - | $239.30M(+106.3%) | $707.40M(+12.1%) |
| Jun 2022 | - | $116.00M(-51.6%) | $630.80M(-8.2%) |
| Mar 2022 | - | $239.90M(+113.8%) | $687.40M(+44.5%) |
| Dec 2021 | $475.80M(-7.6%) | $112.20M(-31.0%) | $475.80M(+2.9%) |
| Sep 2021 | - | $162.70M(-5.7%) | $462.40M(-1.8%) |
| Jun 2021 | - | $172.60M(+509.9%) | $470.90M(+16.2%) |
| Mar 2021 | - | $28.30M(-71.4%) | $405.40M(-21.3%) |
| Dec 2020 | $514.80M(-592.6%) | $98.80M(-42.3%) | $514.80M(+9.9%) |
| Sep 2020 | - | $171.20M(+59.9%) | $468.60M(+9.0%) |
| Jun 2020 | - | $107.10M(-22.2%) | $429.80M(-18.6%) |
| Mar 2020 | - | $137.70M(+161.8%) | $527.80M(-605.1%) |
| Dec 2019 | -$104.50M(-117.7%) | $52.60M(-60.3%) | -$104.50M(+13.8%) |
| Sep 2019 | - | $132.40M(-35.4%) | -$91.80M(-22.0%) |
| Jun 2019 | - | $205.10M(-141.5%) | -$117.70M(-21.5%) |
| Mar 2019 | - | -$494.60M(-857.4%) | -$149.90M(-125.4%) |
| Dec 2018 | $589.20M(+41.0%) | $65.30M(-38.7%) | $589.20M(+8.5%) |
| Sep 2018 | - | $106.50M(-38.4%) | $542.90M(-23.8%) |
| Jun 2018 | - | $172.90M(-29.3%) | $712.70M(+47.3%) |
| Mar 2018 | - | $244.50M(+1186.8%) | $483.80M(+15.8%) |
| Dec 2017 | $417.90M(-41.4%) | $19.00M(-93.1%) | $417.90M(-17.9%) |
| Sep 2017 | - | $276.30M(-593.4%) | $509.20M(+29.0%) |
| Jun 2017 | - | -$56.00M(-131.4%) | $394.70M(-39.9%) |
| Mar 2017 | - | $178.60M(+61.9%) | $656.80M(-8.0%) |
| Dec 2016 | $713.70M(+9.5%) | $110.30M(-31.8%) | $713.70M(+0.8%) |
| Sep 2016 | - | $161.80M(-21.5%) | $708.00M(-29.9%) |
| Jun 2016 | - | $206.10M(-12.5%) | $1.01B(+11.8%) |
| Mar 2016 | - | $235.50M(+125.1%) | $903.70M(+38.7%) |
| Dec 2015 | $651.60M(+91.6%) | $104.60M(-77.5%) | $651.60M(-1.7%) |
| Sep 2015 | - | $464.40M(+368.1%) | $662.96M(+282.5%) |
| Jun 2015 | - | $99.20M(-697.6%) | $173.32M(-6.8%) |
| Mar 2015 | - | -$16.60M(-114.3%) | $185.98M(-45.3%) |
| Dec 2014 | $340.10M(+94.8%) | $115.96M(-559.5%) | $340.10M(+75.5%) |
| Sep 2014 | - | -$25.24M(-122.6%) | $193.82M(-31.2%) |
| Jun 2014 | - | $111.85M(-18.7%) | $281.75M(+12.8%) |
| Mar 2014 | - | $137.52M(-553.7%) | $249.76M(+43.1%) |
| Dec 2013 | $174.56M(-42.7%) | -$30.31M(-148.4%) | $174.56M(-39.4%) |
| Sep 2013 | - | $62.69M(-21.5%) | $288.13M(-5.1%) |
| Jun 2013 | - | $79.86M(+28.1%) | $303.56M(+2.5%) |
| Mar 2013 | - | $62.33M(-25.1%) | $296.01M(-2.8%) |
| Dec 2012 | $304.44M(+39.7%) | $83.25M(+6.6%) | $304.44M(+15.2%) |
| Sep 2012 | - | $78.11M(+8.0%) | $264.38M(-2.3%) |
| Jun 2012 | - | $72.32M(+2.2%) | $270.66M(-0.6%) |
| Mar 2012 | - | $70.76M(+63.8%) | $272.24M(+25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $217.87M(+105.7%) | $43.19M(-48.8%) | $217.87M(+18.3%) |
| Sep 2011 | - | $84.40M(+14.2%) | $184.22M(+32.0%) |
| Jun 2011 | - | $73.89M(+350.8%) | $139.56M(+35.0%) |
| Mar 2011 | - | $16.39M(+71.7%) | $103.38M(-2.4%) |
| Dec 2010 | $105.92M(+444.2%) | $9.54M(-76.0%) | $105.92M(+13.8%) |
| Sep 2010 | - | $39.74M(+5.4%) | $93.04M(+42.6%) |
| Jun 2010 | - | $37.71M(+99.2%) | $65.24M(+159.0%) |
| Mar 2010 | - | $18.93M(-668.4%) | $25.19M(+29.5%) |
| Dec 2009 | $19.46M(-139.5%) | -$3.33M(-127.9%) | $19.46M(-132.8%) |
| Sep 2009 | - | $11.94M(-609.3%) | -$59.28M(-1.6%) |
| Jun 2009 | - | -$2.34M(-117.8%) | -$60.25M(+38.3%) |
| Mar 2009 | - | $13.20M(-116.1%) | -$43.57M(-4.0%) |
| Dec 2008 | -$49.33M(-348.4%) | -$82.07M(-848.1%) | -$45.37M(-217.3%) |
| Sep 2008 | - | $10.97M(-23.5%) | $38.69M(-9.1%) |
| Jun 2008 | - | $14.33M(+25.7%) | $42.57M(+25.0%) |
| Mar 2008 | - | $11.40M(+474.2%) | $34.04M(+71.4%) |
| Dec 2007 | $19.86M(-73.2%) | $1.99M(-86.6%) | $19.86M(-72.9%) |
| Sep 2007 | - | $14.85M(+155.7%) | $73.38M(+9.5%) |
| Jun 2007 | - | $5.81M(-308.8%) | $67.01M(-2.7%) |
| Mar 2007 | - | -$2.78M(-105.0%) | $68.88M(-6.9%) |
| Dec 2006 | $73.97M(+13.8%) | $55.51M(+554.7%) | $73.97M(+54.5%) |
| Sep 2006 | - | $8.48M(+10.5%) | $47.87M(-13.2%) |
| Jun 2006 | - | $7.67M(+232.6%) | $55.15M(-7.6%) |
| Mar 2006 | - | $2.31M(-92.2%) | $59.66M(-8.2%) |
| Dec 2005 | $65.02M(+320.8%) | $29.41M(+86.6%) | $65.02M(+53.0%) |
| Sep 2005 | - | $15.76M(+29.4%) | $42.49M(+28.8%) |
| Jun 2005 | - | $12.18M(+59.0%) | $33.00M(+32.2%) |
| Mar 2005 | - | $7.66M(+11.2%) | $24.96M(+61.5%) |
| Dec 2004 | $15.45M(-255.0%) | $6.89M(+10.0%) | $15.45M(+189.4%) |
| Sep 2004 | - | $6.27M(+51.4%) | $5.34M(-335.4%) |
| Jun 2004 | - | $4.14M(-324.1%) | -$2.27M(-74.2%) |
| Mar 2004 | - | -$1.85M(-42.6%) | -$8.79M(-11.8%) |
| Dec 2003 | -$9.97M(-57.8%) | -$3.22M(+140.1%) | -$9.97M(+6.6%) |
| Sep 2003 | - | -$1.34M(-43.8%) | -$9.35M(-53.7%) |
| Jun 2003 | - | -$2.38M(-21.2%) | -$20.20M(-3.8%) |
| Mar 2003 | - | -$3.02M(+16.1%) | -$21.00M(-11.2%) |
| Dec 2002 | -$23.65M(-36.6%) | -$2.60M(-78.6%) | -$23.65M(-16.9%) |
| Sep 2002 | - | -$12.19M(+283.3%) | -$28.47M(+9.1%) |
| Jun 2002 | - | -$3.18M(-44.0%) | -$26.10M(-22.2%) |
| Mar 2002 | - | -$5.68M(-23.6%) | -$33.56M(-10.0%) |
| Dec 2001 | -$37.29M(-50.7%) | -$7.43M(-24.3%) | -$37.29M(-39.6%) |
| Sep 2001 | - | -$9.81M(-7.9%) | -$61.73M(+4.7%) |
| Jun 2001 | - | -$10.65M(+13.2%) | -$58.94M(-23.6%) |
| Mar 2001 | - | -$9.40M(-70.5%) | -$77.10M(+2.0%) |
| Dec 2000 | -$75.61M(+125.7%) | -$31.87M(+354.4%) | -$75.61M(+43.9%) |
| Sep 2000 | - | -$7.01M(-75.7%) | -$52.54M(+1.2%) |
| Jun 2000 | - | -$28.81M(+264.2%) | -$51.92M(+77.7%) |
| Mar 2000 | - | -$7.91M(-10.1%) | -$29.21M(-12.8%) |
| Dec 1999 | -$33.50M(+161.7%) | -$8.80M(+37.5%) | -$33.50M(+35.6%) |
| Sep 1999 | - | -$6.40M(+4.9%) | -$24.70M(+35.0%) |
| Jun 1999 | - | -$6.10M(-50.0%) | -$18.30M(+50.0%) |
| Mar 1999 | - | -$12.20M | -$12.20M |
| Dec 1998 | -$12.80M | - | - |
FAQ
- What is United Therapeutics annual net profit?
- What is the all time high annual net income for United Therapeutics?
- What is United Therapeutics annual net income year-on-year change?
- What is United Therapeutics quarterly net profit?
- What is the all time high quarterly net income for United Therapeutics?
- What is United Therapeutics quarterly net income year-on-year change?
- What is United Therapeutics TTM net profit?
- What is the all time high TTM net income for United Therapeutics?
- What is United Therapeutics TTM net income year-on-year change?
What is United Therapeutics annual net profit?
The current annual net income of UTHR is $1.20B
What is the all time high annual net income for United Therapeutics?
United Therapeutics all-time high annual net profit is $1.20B
What is United Therapeutics annual net income year-on-year change?
Over the past year, UTHR annual net profit has changed by +$210.30M (+21.35%)
What is United Therapeutics quarterly net profit?
The current quarterly net income of UTHR is $301.30M
What is the all time high quarterly net income for United Therapeutics?
United Therapeutics all-time high quarterly net profit is $464.40M
What is United Therapeutics quarterly net income year-on-year change?
Over the past year, UTHR quarterly net profit has changed by $0.00 (0.00%)
What is United Therapeutics TTM net profit?
The current TTM net income of UTHR is $1.20B
What is the all time high TTM net income for United Therapeutics?
United Therapeutics all-time high TTM net profit is $1.20B
What is United Therapeutics TTM net income year-on-year change?
Over the past year, UTHR TTM net profit has changed by $0.00 (0.00%)